Market Overview
The global poultry diagnostics market size was valued at USD 530.2 Million in 2024 and is projected to reach USD 1,142.5 Million by 2033. The market is expected to grow at a CAGR of 8.46% during the forecast period 2025-2033. Key growth drivers include rising poultry consumption, frequent disease outbreaks like avian influenza and Newcastle disease, stringent food safety regulations, and technological advancements in diagnostics methods.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
Poultry Diagnostics Market Key Takeaways
- The global poultry diagnostics market size reached USD 530.2 Million in 2024.
- The market is expected to grow at a CAGR of 8.46% during 2025-2033.
- The forecast period for this market is from 2025 to 2033.
- Rising poultry consumption globally is driving demand for diagnostics to ensure flock health and food safety.
- Frequent outbreaks of avian influenza and Newcastle disease have heightened the importance of rapid disease detection.
- Stringent food safety regulations worldwide are increasing the adoption of poultry diagnostics.
- Technological advancements such as PCR and ELISA tests enhance diagnostic speed and accuracy.
Sample Request Link: https://www.imarcgroup.com/poultry-diagnostics-market/requestsample
Market Growth Factors
The increasing demand for poultry products as cheap and low-fat protein is a major factor for market growth. The relationship of poultry (including chickens and turkeys) in diets all over the globe is steadily increasing. If businesses develop proper diagnostic options for maintenance of flock health and security, that is a key factor. Healthy poultry flocks produce more. They resist disease outbreaks. That improves the efficiency of poultry production businesses everywhere.
Avian influenza and Newcastle disease are common poultry diseases causing a risk to poultry production. These diseases damage the economy through infected poultry culling, trade limits, and a drop in consumer trust. In today’s world, poultry diagnostics have become an essential tool for proactive surveillance, intervention, and management of poultry infectious diseases. If detection is fast, outbreaks are controlled through swift quarantine and vaccination, for minimized economic damage and maintained stable poultry industry operations.
Strict food regulations set by governments and by other regulatory bodies worldwide is another factor driving the poultry diagnostics market. Across the globe, regulatory bodies check for compliance with food standards in order to transmit fewer zoonotic diseases. Poultry diagnostics support poultry producers to adhere to food safety regulations for poultry products, avoid product recalls, and maintain consumer confidence. Diagnostic tests see increased use in meat and poultry processing like polymerase chain reaction or enzyme-linked immunosorbent assay. The market growth has also increased.
Market Segmentation
Breakup by Disease Type:
- Avian Influenza: Represents the largest segment due to its highly contagious nature and zoonotic potential, driving prioritization of diagnostic testing and control measures.
- Avian Salmonellosis
- Avian Mycoplasmosis
- Infectious Bronchitis
- Infectious Bursal Disease
- Newcastle Disease
- Chicken Anemia
- Others
Breakup by Test Type:
- ELISA Test: Holds the largest market share due to its versatility, high sensitivity and specificity, cost-effectiveness, and broad applicability in detecting multiple poultry diseases.
- PCR Test
- Others
Breakup by Service:
- Bacteriology: The leading segment, focusing on the detection and characterization of bacterial pathogens such as Salmonella and E. coli that significantly impact poultry health and food safety.
- Parasitology
- Virology
Regional Insights
North America dominates the poultry diagnostics market, accounting for the largest market share. The region’s well-established and industrialized poultry sector, particularly in the United States, demands rigorous disease management to ensure flock health and product quality. Additionally, stringent regulatory frameworks and elevated consumer expectations for food safety fuel investments in advanced diagnostic technologies. The presence of leading diagnostic companies, research institutions, and an advanced veterinary infrastructure further supports the adoption of poultry diagnostics in North America.
Recent Developments & News
In 2022, IDEXX Laboratories Inc. launched new diagnostic tests and a software application to assist poultry health management. Qiagen introduced advanced molecular diagnostic solutions including DNA and RNA-based tests to detect various poultry pathogens. Thermo Fisher Scientific Inc. developed innovative PCR-based testing kits and diagnostic instruments to accurately detect poultry diseases. These advancements reflect ongoing innovation and investment in poultry diagnostics by leading industry players.
Key Players
- AgroBioTek Laboratories
- BioChek B.V.
- Bionote Co. Ltd.
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories Inc.
- MEGACOR Diagnostik GmbH
- QIAGEN N.V.
- Gezondheidsdienst voor Dieren B.V. (Royal GD)
- Thermo Fisher Scientific Inc.
- Zoetis Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request For Customization: https://www.imarcgroup.com/request?type=report&id=4381&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
